← Return to Pancreatic Cancer Surgery Q&A July 21-25 w/ Dr. Poruk, Mayo Clinic

Discussion
Comment receiving replies
Profile picture for markymarkfl @markymarkfl

Thanks to moderators for setting this up and to all the docs for participating!

For Dr. Poruk:

Same question I posed to Dr. Stauffer in his discussion ( https://connect.mayoclinic.org/discussion/pancreatic-cancer-qa-with-dr-stauffer-mayo-surgeon-may-29/ ) which was inspired by a paper you co-authored in 2016 ( https://pubmed.ncbi.nlm.nih.gov/27215900/ ):

"Given the high rate of recurrence after Whipple, what are your latest thoughts on total pancreatectomy, especially for younger PDAC patients or patients with mutations predisposing them to more PDAC development?"

What are the other major concerns beyond lifetime enzyme and insulin dependence, which a patient may already have?

Also, how difficult is it to preserve a spleen when doing a distal or total pancreatectomy?

Jump to this post


Replies to "Thanks to moderators for setting this up and to all the docs for participating! For Dr...."

Th risk to benefit far outweighs a total pancreatectomy. The vast majority of progression is not from a new primary developing in the remnant pancreas or not having an RO margin, it is because there is micrometastatic disease that has already occurred and undetectable by conventional imaging methods. Doing a complete pancreatectomy will do nothing about micrometastatic disease. I cases where there is certain germline mutations that are associated with repeated development of new primary cancers making a family member diagnosed with pancreatic cancer an extreme risk to develop a new primary, then a surgeon would entertain that possibility of removing the entire pancreas vs waiting and frequent surveillance.

There are many factors that go into a decision to remove the entire pancreas. In general, it is rarely done for pancreas adenocarcinoma when we are able to do a Whipple or a distal pancreatectomy. Mainly, this is because the vast majority of recurrences are not within the pancreas, but are to distant organs such as the liver or lungs. Removing the whole pancreas does not seem to prevent this. For cases of cancer, we do not preserve the spleen, as there are important lymph nodes near the spleen that need to be removed to properly "stage" the cancer. We will rarely preserve the spleen for pre-cancerous lesions or certain types of neuroendocrine cancers, but this also depends on many patient factors.